A clinical trial for potential Ebola vaccines demonstrated an immune response lasting up to one year and what scientists consider salient data, according to results recently published in the New England Journal of Medicine.

To boost support for caregivers on an international scale, Merck KGaA of Darmstadt, Germany, launched a worldwide program called Embracing Carers and presented recent survey results at a conference in Australia.

The future of Wisconsin's $750,000 cap on noneconomic damages is up to the state's Supreme Court, the American Medical Association reported.

Kahn Academy, a nonprofit based in Mountain View, California, that provides free online educational programs, was recently awarded a a $3-million, three-year grant from the Amgen Foundation to create new online biology programs ranging from ninth grade lessons through the Advance Placement Program.

The U.S. Food and Drug Administration agreed to review Amgen’s supplemental biologics license application for Prolia (denosumab), a drug targeting patients with glucocorticoid-induced osteoporosis (GIOP), an Amgen release said.

The American Hospital Association (AHA) is speaking out against the recent executive order regarding health care signed by President Donald Trump, warning of the repercussions the order would have on the millions of Americans who are managing chronic and other pre-existing conditions.

Apricus Biosciences said in a release that its CEO, Richard Pascoe, recently addressed the 2017 BIO Investor Forum in San Francisco, where he updated attendees on the company’s Vitaros, an erectile dysfunction treatment under development in the U.S.

Astellas Pharma, and Seattle Genetics recently began dosing the first patient in a registrational, phase two clinical trial of enfortumab vedotin for patients with certain forms of urothelial bladder cancer.

The American Medical Association (AMA) is helping those studying for the United States Medical Licensing Examination (USMLE) Step 2 exam by highlighting questions on its website that test preppers often miss.

As crews worked to battle wildfires ravaging California, acting Health and Human Services Secretary Eric Hargan declared a public health emergency in that state.

Eli Lilly and Co. has declared a fourth-quarter dividend of 52 cents per share on outstanding common stock.

A recent study by the National Institutes of Health (NIH) shows women with gestational diabetes can decrease and eliminate their threat of cardiovascular disease by following a healthy lifestyle.

The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) and California Institute of Technology researchers recently detailed criteria for developing a universal influenza vaccine, publishing their results in Immunity.

Amgen said in a release it is teaming up with Boston Children's Hospital to collaborate on neuroscience research to help identify pain targets based on genetic analyses.

The U.S. Food and Drug Administration (FDA) recently granted fast track designation to Astellas Pharma to develop gilteritinib, an investigational compound, for patients with FLT3 mutation-positive (FLT3+) relapsed or refractory acute myeloid leukemia (AML).

Wake Forest Baptist Medical Center has received a $9.2 million grant from the National Cancer Institute for research in developing more effective treatments for glioblastoma patients.

When a sudden bacterial illness resulted in multiple amputations and near loss of life for Hugh Gerlach, Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, provided intensive rehabilitation to restore his life quality.

Many patients are not being provided information on health care costs, particularly for emergency procedures, a new survey has found.

Ever wonder how to safely dispose of unwanted or expired prescription pills? As part of National Prescription Drug Take Back Day, Oct. 28, numerous locations around the country will be accepting unwanted prescription pills.

Abbott recently said its Proclaim DRG Neurostimulator System, which stimulates dorsal root ganglion (DRG) and eases pain in patients with complex regional pain syndrome (CRPS) of the lower limbs, has been launched in the U.S.